United Laboratories International Holdings Future Growth
Future criteria checks 0/6
United Laboratories International Holdings's earnings are forecast to decline at 0.7% per annum while its annual revenue is expected to grow at 6.6% per year. EPS is expected to decline by 0.7% per annum. Return on equity is forecast to be 16.4% in 3 years.
Key information
-0.7%
Earnings growth rate
-0.7%
EPS growth rate
Pharmaceuticals earnings growth | 23.5% |
Revenue growth rate | 6.6% |
Future return on equity | 16.4% |
Analyst coverage | Good |
Last updated | 26 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 15,408 | 2,167 | N/A | 2,875 | 6 |
12/31/2024 | 14,549 | 2,110 | N/A | 3,112 | 7 |
12/31/2023 | 13,608 | 2,080 | N/A | 2,374 | 7 |
6/30/2023 | 13,059 | 2,236 | 1,637 | 2,568 | N/A |
3/31/2023 | 12,197 | 1,909 | 1,444 | 2,300 | N/A |
12/31/2022 | 11,334 | 1,581 | 1,251 | 2,031 | N/A |
9/30/2022 | 10,750 | 1,288 | 1,066 | 1,683 | N/A |
6/30/2022 | 10,166 | 995 | 882 | 1,336 | N/A |
3/31/2022 | 9,935 | 991 | 968 | 1,439 | N/A |
12/31/2021 | 9,703 | 988 | 1,055 | 1,543 | N/A |
9/30/2021 | 9,445 | 1,056 | 1,047 | 1,647 | N/A |
6/30/2021 | 9,187 | 1,123 | 1,039 | 1,752 | N/A |
3/31/2021 | 8,980 | 913 | 1,035 | 1,660 | N/A |
12/31/2020 | 8,772 | 703 | 1,030 | 1,568 | N/A |
9/30/2020 | 8,690 | 626 | 1,128 | 1,625 | N/A |
6/30/2020 | 8,607 | 549 | 1,226 | 1,683 | N/A |
3/31/2020 | 8,500 | 595 | 1,293 | 1,742 | N/A |
12/31/2019 | 8,393 | 642 | 1,361 | 1,801 | N/A |
9/30/2019 | 8,100 | 765 | 1,147 | 1,618 | N/A |
6/30/2019 | 7,808 | 888 | 932 | 1,436 | N/A |
3/31/2019 | 7,659 | 785 | 806 | 1,324 | N/A |
12/31/2018 | 7,511 | 683 | 681 | 1,213 | N/A |
9/30/2018 | 7,395 | 373 | 640 | 1,104 | N/A |
6/30/2018 | 7,280 | 64 | 599 | 995 | N/A |
3/31/2018 | 7,053 | 73 | 447 | 883 | N/A |
12/31/2017 | 6,827 | 82 | 296 | 770 | N/A |
9/30/2017 | 6,640 | -34 | 418 | 957 | N/A |
6/30/2017 | 6,454 | -150 | 541 | 1,144 | N/A |
3/31/2017 | 6,266 | -211 | N/A | 1,109 | N/A |
12/31/2016 | 6,078 | -272 | N/A | 1,074 | N/A |
9/30/2016 | 6,083 | -216 | N/A | 976 | N/A |
6/30/2016 | 6,076 | -159 | N/A | 875 | N/A |
3/31/2016 | 6,195 | -32 | N/A | 1,182 | N/A |
12/31/2015 | 6,446 | 92 | N/A | 1,516 | N/A |
9/30/2015 | 6,597 | 148 | N/A | 1,522 | N/A |
6/30/2015 | 6,711 | 201 | N/A | 1,521 | N/A |
3/31/2015 | 6,565 | 373 | N/A | 1,460 | N/A |
12/31/2014 | 6,422 | 545 | N/A | 1,400 | N/A |
9/30/2014 | 6,179 | 552 | N/A | 1,436 | N/A |
6/30/2014 | 6,101 | 574 | N/A | 1,511 | N/A |
3/31/2014 | 6,112 | 306 | N/A | 1,347 | N/A |
12/31/2013 | 5,972 | 38 | N/A | 1,155 | N/A |
9/30/2013 | 5,829 | 33 | N/A | 924 | N/A |
6/30/2013 | 5,639 | 28 | N/A | 682 | N/A |
3/31/2013 | 5,662 | 79 | N/A | 581 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ULIH.F's earnings are forecast to decline over the next 3 years (-0.7% per year).
Earnings vs Market: ULIH.F's earnings are forecast to decline over the next 3 years (-0.7% per year).
High Growth Earnings: ULIH.F's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ULIH.F's revenue (6.6% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: ULIH.F's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ULIH.F's Return on Equity is forecast to be low in 3 years time (16.4%).